Merck Awarded Summary Judgment in Zocor Injury Case

NEW ORLEANS - Merck was awarded summary judgment in a case filed by a man who claimed Zocor was unreasonably dangerous because his use of the cholesterol-lowering drug caused him to suffer rhabdomyolysis, after a federal judge found the man could not proffer expert testimony to support his allegations. Jimmie Ray Sheridan v. Merck & Co., Inc. No. 02-2581 (E.D. La.).

In a minute entry dated Dec. 8, 2003, U.S. District Judge A.J. McNamara ruled that the depositions of the plaintiff's experts failed to support his claims that Zocor is defective, and that Merck failed to warn of the risks …